Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Curr Obes Rep ; 8(4): 373-412, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31701349

ABSTRACT

PURPOSE OF REVIEW: Misperception of children's weight status is prevalent among parents and children themselves and may impact parents' and children's health behaviors. This study was conducted in order to provide a descriptive systematic review of research on factors influencing parents' and children's misperceptions of children's weight status published in the past 5 years. RECENT FINDINGS: Factors studied most often in relation to parents' and children's misperception included children's weight status, gender, and age, as well as parents' weight status, parental education levels and socioeconomic status, and ethnicity. Most determinants that were found to have a significant influence on misperception in parents also did in children. The literature on misperception of children's weight status is extensive. Most determinants assessed in included studies were known determinants of childhood obesity. Further research should be directed toward better understanding the impact of weight status perception (whether it is accurate or not) on health behaviors and weight gain over time.


Subject(s)
Body Weight , Health Behavior , Pediatric Obesity , Adolescent , Body Mass Index , Body Size , Child , Child, Preschool , Databases, Factual , Female , Health Knowledge, Attitudes, Practice , Humans , Male , Overweight , Parents , Perception , Weight Gain
2.
Anesth Analg ; 126(3): 920-924, 2018 03.
Article in English | MEDLINE | ID: mdl-28858899

ABSTRACT

BACKGROUND: Experts recommend postpartum oxytocin to prevent uterine atony and hemorrhage, but oxytocin may be associated with dose-dependent adverse effects, and the correct dose of postpartum oxytocin has yet to be determined. The effective dose in 90% of patients (ED90) of oxytocin after cesarean delivery may be higher in patients exposed to oxytocin during labor compared to patients unexposed. We therefore undertook this study to compare postpartum oxytocin requirements in patients exposed to oxytocin prior to cesarean delivery versus those not exposed, when all were treated according to a specific institutional protocol. METHODS: In this retrospective chart review, we reviewed medical records of patients who underwent cesarean delivery under neuraxial anesthesia and noted demographic data, relevant comorbidities, and oxytocin exposure, infusion rate, and duration prior to delivery. Patients exposed to oxytocin before cesarean (OXY+ group) were compared to those not exposed (OXY- group). The primary outcome variable was highest infusion rate of postpartum oxytocin required per institutional protocol. Secondary outcomes included estimated blood loss, proportion of patients with postpartum hemorrhage, and proportions who received other uterotonic medications or red blood cell transfusion. RESULTS: OXY+ patients were more likely to be nulliparous and had higher estimated gestational age and neonatal weight than OXY- patients. They also had higher incidence of chorioamnionitis and lower incidence of multiple gestation. OXY+ patients required a high postpartum oxytocin infusion rate more often than OXY- patients (adjusted odds ratio 1.94 [95% confidence interval, 1.19-3.15; P = .008]). They also received other uterotonic agents more commonly. Estimated blood loss, hemorrhage rates, and transfusion rates did not differ between groups. CONCLUSIONS: Reported increases in the ED90 of postpartum oxytocin after oxytocin exposure during labor appear to be clinically significant. We have therefore altered our institutional protocol so that women preexposed to oxytocin routinely receive higher initial postpartum oxytocin infusion rates.


Subject(s)
Cesarean Section/trends , Oxytocics/administration & dosage , Oxytocin/administration & dosage , Postnatal Care/trends , Adult , Dose-Response Relationship, Drug , Female , Humans , Labor, Obstetric/drug effects , Labor, Obstetric/physiology , Pregnancy , Retrospective Studies
3.
Curr Opin Anaesthesiol ; 29(5): 539-43, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27380045

ABSTRACT

PURPOSE OF REVIEW: Intraoperative neurophysiologic monitoring (IONM) has been rapidly adopted as a standard monitoring technique for a growing number of surgical procedures. This article offers a basic review of IONM and discusses some of its latest applications and anesthetic techniques that optimize monitoring conditions. RECENT FINDINGS: IONM has been demonstrated to alert the surgical team to potential injury and can also be used to detect impending positioning injuries. Upper extremity somatosensory evoked potential monitoring is particularly helpful in preventing ulnar neuropathy that is more common in patients who are positioned prone and with severe arm abduction. Somatosensory evoked potential monitoring has a high specificity for vascular compromise and neurologic ischemia that may occur during neurovascular procedures. Electroencephalography is also helpful in alerting the surgical and anesthesia teams to an impending ischemic event. Although a total intravenous anesthesia technique offers better monitoring conditions, propofol may prolong emergence. SUMMARY: IONM is commonly used in a growing number and variety of surgical procedures, and has been shown to improve outcomes. IONM poses challenges for the anesthesiologist, but tailoring the anesthetic to be compatible with the monitoring techniques in use can help to prevent surgical complications.


Subject(s)
Anesthesia/methods , Evoked Potentials, Somatosensory/drug effects , Intraoperative Neurophysiological Monitoring/methods , Intraoperative Neurophysiological Monitoring/statistics & numerical data , Neurosurgical Procedures/adverse effects , Anesthesia/adverse effects , Anesthetics/administration & dosage , Anesthetics/adverse effects , Brain Ischemia/diagnosis , Brain Ischemia/prevention & control , Electroencephalography , Electromyography , Evoked Potentials, Motor/drug effects , Humans , Patient Positioning , Upper Extremity/innervation
4.
Clin J Oncol Nurs ; 12(1): 131-40, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18258583

ABSTRACT

Depression and depressive symptoms are prevalent in people with cancer, yet interventions for depression are a low priority for most oncology care providers. Barriers to diagnosis and treatment include beliefs by patients and providers that depression is an expected correlate of cancer diagnosis, the reluctance of patients to share psychological concerns, and the reticence of some professionals to assess patients with cancer for depressive symptoms in the midst of busy oncology settings. Intervening to diminish depressive symptoms in people with cancer is important because depression has been associated with poorer quality of life, recovery, and possibly survival. This article reviews and summarizes the evidence for pharmacologic and nonpharmacologic interventions for people with cancer and depression and identifies opportunities for future research and practice change.


Subject(s)
Depressive Disorder/therapy , Evidence-Based Medicine/organization & administration , Neoplasms/complications , Nursing Evaluation Research/organization & administration , Oncology Nursing/organization & administration , Antidepressive Agents/therapeutic use , Cognitive Behavioral Therapy , Complementary Therapies , Depressive Disorder/diagnosis , Depressive Disorder/epidemiology , Depressive Disorder/etiology , Humans , Mass Screening , Neoplasms/psychology , Nurse's Role , Nursing Assessment , Patient Education as Topic , Practice Guidelines as Topic , Prevalence , Self-Help Groups , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...